Tandem Diabetes Care Reports First Quarter 2015 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/19/2026
- US stock futures steady after tech slump; investors focus on Middle East tensions
- U.S. Treasury doubles buyback operation size for long-dated bonds
- Marvell shares jump after giving Google warrants amid custom chip deal
- U.S. debt tops $40 trillion
- Nvidia credit risk gauge hits new peak as SoftBank readies record bond issue
- Marvell issues Google warrant tied to custom chip deal
- Tech selloff weighs down Wall Street as bond yields climb
- FOMC minutes from July 28-29th meeting
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
Tandem Diabetes (TNDM) Misses Q1 EPS by 4c, Affirms Guidance
April 30, 2015 4:55 PM EDTTandem Diabetes (NASDAQ: TNDM) reported Q1 EPS of ($0.83), $0.04 worse than the analyst estimate of ($0.79). Revenue for the quarter came in at $12.3 million versus the consensus estimate of $12.19 million. Tandem Diabetes reaffirmed FY2015 guidance.
For the year ending December 31, 2015, the Company affirms its... More
